The Heart of Healthcare | A Digital Health Podcast
Why Is Everyone Talking About Ozempic? | Found CEO Sarah Jones Simmer
Nov 13, 2023
The CEO of Found, the largest medically-supported weight care clinic in the country, discusses the failures of the weight loss industry, the rise of GLP1 medications for weight loss, responsible prescribing, and the potential of telehealth in obesity treatment.
35:51
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Obesity needs to be treated as a chronic condition with a personalized, multifactorial approach rather than focusing on vanity and personal failing.
- GLP-1 medications like Semaglutide have shown significant results in treating obesity, but responsible prescribing by qualified healthcare professionals is essential.
Deep dives
Obesity as a Disease
Obesity is a significant public health problem that affects close to 70% of Americans. It should be treated as a chronic condition rather than a personal failing. The traditional approach of simply telling people to eat less and exercise more has been ineffective. Obesity has multiple root causes, such as brain hunger and metabolic factors. The weight loss industry has often treated obesity as a vanity issue rather than focusing on health. To address obesity successfully, a multifactorial and personalized approach is needed.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
